These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 17194552)
41. Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Dawe PS; Flanagan FO; Madekurozwa RL; Sorensen KJ; Anderson EC; Foggin CM; Ferris NP; Knowles NJ Vet Rec; 1994 Mar; 134(10):230-2. PubMed ID: 8197679 [TBL] [Abstract][Full Text] [Related]
42. Longitudinal study to investigate the role of impala (Aepyceros melampus) in foot-and-mouth disease maintenance in the Kruger National Park, South Africa. Vosloo W; Thompson PN; Botha B; Bengis RG; Thomson GR Transbound Emerg Dis; 2009 Mar; 56(1-2):18-30. PubMed ID: 19200295 [TBL] [Abstract][Full Text] [Related]
43. Phylogenetic structure of serotype A foot-and-mouth disease virus: global diversity and the Indian perspective. Mohapatra JK; Subramaniam S; Pandey LK; Pawar SS; De A; Das B; Sanyal A; Pattnaik B J Gen Virol; 2011 Apr; 92(Pt 4):873-9. PubMed ID: 21228130 [TBL] [Abstract][Full Text] [Related]
44. Potential for the transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle. Anderson EC Res Vet Sci; 1986 Mar; 40(2):278-80. PubMed ID: 3010415 [TBL] [Abstract][Full Text] [Related]
45. Foot-and-mouth disease and the African buffalo (Syncerus caffer). II. Virus excretion and transmission during acute infection. Gainaru MD; Thomson GR; Bengis RG; Esterhuysen JJ; Bruce W; Pini A Onderstepoort J Vet Res; 1986 Jun; 53(2):75-85. PubMed ID: 3014419 [TBL] [Abstract][Full Text] [Related]
46. Persistent Infection of African Buffalo (Syncerus caffer) with Foot-and-Mouth Disease Virus: Limited Viral Evolution and No Evidence of Antibody Neutralization Escape. Cortey M; Ferretti L; Pérez-Martín E; Zhang F; de Klerk-Lorist LM; Scott K; Freimanis G; Seago J; Ribeca P; van Schalkwyk L; Juleff ND; Maree FF; Charleston B J Virol; 2019 Aug; 93(15):. PubMed ID: 31092573 [TBL] [Abstract][Full Text] [Related]
47. Re-emergence of foot-and-mouth disease in Botswana. Baipoledi EK; Matlho G; Letshwenyo M; Chimbombi M; Adom EK; Raborokgwe MV; Hyera JM Vet J; 2004 Jul; 168(1):93-9. PubMed ID: 15158214 [TBL] [Abstract][Full Text] [Related]
48. Genetic characterization of Indian type O FMD virus 3A region in context with host cell preference. Maroudam V; Nagendrakumar SB; Rangarajan PN; Thiagarajan D; Srinivasan VA Infect Genet Evol; 2010 Jul; 10(5):703-9. PubMed ID: 20302973 [TBL] [Abstract][Full Text] [Related]
49. Genetic characterization of type A foot-and-mouth disease virus 3A region in context of the reemergence of VP359-deletion lineage in India. Mohapatra JK; Sahu A; Pandey L; Sanyal A; Hemadri D; Pattnaik B Infect Genet Evol; 2009 Jul; 9(4):483-92. PubMed ID: 19460313 [TBL] [Abstract][Full Text] [Related]
50. Phylogeny, genome evolution, and antigenic variability among endemic foot-and-mouth disease virus type A isolates from India. Mittal M; Tosh C; Hemadri D; Sanyal A; Bandyopadhyay SK Arch Virol; 2005 May; 150(5):911-28. PubMed ID: 15662482 [TBL] [Abstract][Full Text] [Related]
51. Antibodies against foot-and-mouth disease (FMD) virus in African buffalos (Syncerus caffer) in selected National Parks in Uganda (2001-2003). Ayebazibwe C; Mwiine FN; Balinda SN; Tjørnehøj K; Masembe C; Muwanika VB; Okurut AR; Siegismund HR; Alexandersen S Transbound Emerg Dis; 2010 Aug; 57(4):286-92. PubMed ID: 20561289 [TBL] [Abstract][Full Text] [Related]
52. Disease constraints for utilization of the African buffalo (Syncerus caffer) on game ranches in Zambia. Munang'andu HM; Siamudaala VM; Nambota A; Bwalya JM; Munyeme M; Mweene AS; Takada A; Kida H Jpn J Vet Res; 2006 May; 54(1):3-13. PubMed ID: 16786973 [TBL] [Abstract][Full Text] [Related]
53. Experimental transmission of foot-and-mouth disease among Indian buffalo (Bubalus bubalis) and from buffalo to cattle. Maroudam V; Nagendrakumar SB; Madhanmohan M; Santhakumar P; Thiagarajan D; Srinivasan VA J Comp Pathol; 2008; 139(2-3):81-5. PubMed ID: 18619607 [TBL] [Abstract][Full Text] [Related]
54. Reconstructing geographical movements and host species transitions of foot-and-mouth disease virus serotype SAT 2. Hall MD; Knowles NJ; Wadsworth J; Rambaut A; Woolhouse ME mBio; 2013 Oct; 4(5):e00591-13. PubMed ID: 24149511 [TBL] [Abstract][Full Text] [Related]
55. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India. Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900 [TBL] [Abstract][Full Text] [Related]
56. Molecular differentiation and phylogenetic analysis of the Egyptian foot-and-mouth disease virus SAT2. El-Shehawy LI; Abu-Elnaga HI; Rizk SA; Abd El-Kreem AS; Mohamed AA; Fawzy HG Arch Virol; 2014 Mar; 159(3):437-43. PubMed ID: 24046086 [TBL] [Abstract][Full Text] [Related]
57. Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012. Ahmed HA; Salem SA; Habashi AR; Arafa AA; Aggour MG; Salem GH; Gaber AS; Selem O; Abdelkader SH; Knowles NJ; Madi M; Valdazo-González B; Wadsworth J; Hutchings GH; Mioulet V; Hammond JM; King DP Transbound Emerg Dis; 2012 Dec; 59(6):476-81. PubMed ID: 23025522 [TBL] [Abstract][Full Text] [Related]
58. Genetic diversity of foot-and-mouth disease virus serotype O in Pakistan and Afghanistan, 1997-2009. Jamal SM; Ferrari G; Ahmed S; Normann P; Belsham GJ Infect Genet Evol; 2011 Aug; 11(6):1229-38. PubMed ID: 21419880 [TBL] [Abstract][Full Text] [Related]
59. Genetic and antigenic analysis of two recently circulating genotypes of type A foot-and-mouth disease virus in India: evidence for positive selection in the capsid-coding genes. Tosh C; Hemadri D; Sanyal A; Bandyopadhyay SK Arch Virol; 2003 May; 148(5):853-69. PubMed ID: 12721795 [TBL] [Abstract][Full Text] [Related]
60. Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field. Sangula AK; Siegismund HR; Belsham GJ; Balinda SN; Masembe C; Muwanika VB Epidemiol Infect; 2011 Feb; 139(2):189-96. PubMed ID: 20334728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]